Impact of resumption of Oral AntiCoagulation therapy (OAC) after GastroIntestinal Bleeding (GIB) on clinical outcomes in patients with Non-Valvular Atrial Fibrillation (NVAF)

被引：0
|
作者：
Sun, W. [1 ]
Yan, B. [1 ]
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.595
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Persistence to Oral Anticoagulation Treatment in Non-valvular Atrial Fibrillation Patients in the United States
    Dhamane, Amol
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Keshishian, Allison
    CIRCULATION, 2020, 142
  • [22] Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
    Deitelzweig, Steven
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Jiang, Jenny
    Yuce, Huseyin
    Lip, Gregory Y. H.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [23] The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation
    Van den Ham, H. A.
    Klungel, O. H.
    Leufkens, H. G. M.
    Van Staa, T. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 107 - 115
  • [24] Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
    Wu, Jia
    Zhang, Yonggang
    Liao, Xiaoyang
    Lei, Yi
    FRONTIERS IN MEDICINE, 2020, 7
  • [25] Defining non-valvular atrial fibrillation while selecting anticoagulation therapy
    Garg, Pankaj
    Ripley, David P.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (02) : 66 - 67
  • [26] Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
    Marieke G. M. Weernink
    Melissa C. W. Vaanholt
    Catharina G. M. Groothuis-Oudshoorn
    Clemens von Birgelen
    Maarten J. IJzerman
    Janine A. van Til
    American Journal of Cardiovascular Drugs, 2018, 18 : 493 - 502
  • [27] Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
    Weernink, Marieke G. M.
    Vaanholt, Melissa C. W.
    Groothuis-Oudshoorn, Catharina G. M.
    von Birgelen, Clemens
    IJzerman, Maarten J.
    van Til, Janine A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 493 - 502
  • [28] The Comparative Safety and Effectiveness of the Oral Anticoagulant (OAC) Dabigatran versus Warfarin Utilized in a Large Healthcare System in Non-valvular Atrial Fibrillation (NVAF) Patients
    Villines, Todd C.
    Schnee, Janet
    Fraeman, Kathy
    Siu, Kimberly
    Reynolds, Matthew W.
    Collins, Jenna
    CIRCULATION, 2014, 130
  • [29] Potential impact of apixaban on formulary budget and clinical outcomes in non-valvular atrial fibrillation patients
    Kachroo, S.
    Kuznik, A.
    Liu, X.
    Gosden, T.
    Budd, D.
    Lister, S.
    Phatak, H.
    EUROPEAN HEART JOURNAL, 2014, 35 : 896 - 896
  • [30] Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
    Atwater, Brett D.
    Di Fusco, Manuela
    Keshishian, Allison
    Delinger, Rachel
    Ferri, Mauricio
    Jiang, Jenny
    Seigel, Lauren
    Yuce, Huseyin
    Guo, Jennifer D.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (04) : 626 - 634
12345